Related Experiment Video
Updated: Sep 25, 2025
04:03
Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
Published on: September 27, 2024
921
Future Perspectives of Revaluating Mild COPD.
Dejan Radovanovic1, Marco Contoli2, Fulvio Braido3
1Division of Respiratory Diseases, Ospedale L. Sacco, ASST Fatebenefratelli-Sacco, Milan, Italy.
Respiration; International Review of Thoracic Diseases
|April 25, 2022
Summary
Mild COPD requires careful evaluation beyond spirometry. Early detection of lung damage, even with mild obstruction, is crucial for managing chronic obstructive pulmonary disease (COPD) and improving patient outcomes.
Area of Science:
- Pulmonary Medicine
- Respiratory Disease Research
Background:
- Chronic Obstructive Pulmonary Disease (COPD) is a major global health burden, ranking as the third leading cause of death worldwide in 2020.
- Current COPD staging relies heavily on airflow obstruction (FEV1), categorizing severity from mild (GOLD 1) to very severe (GOLD 4).
Purpose of the Study:
- To critically analyze the definition and implications of "mild COPD."
- To highlight the limitations of spirometry in assessing early-stage COPD.
- To emphasize the importance of early identification and intervention for chronic obstructive pulmonary disease.
Main Methods:
- Review of existing studies on COPD pathophysiology and diagnosis.
- Analysis of the correlation between small airways pathology, symptoms, and disease progression.
- Evaluation of the inadequacy of conventional tests, including spirometry, for early COPD detection.
Main Results:
- Even with mild airflow obstruction, patients can experience significant symptoms, physiological decline, emphysema, and recurrent exacerbations.
- Small airways pathology, particularly bronchiolitis, precedes emphysema and is strongly linked to symptom presence.
- Conventional diagnostic tests, including spirometry, often fail to detect these early pathological changes in mild COPD.
Conclusions:
- Relying solely on spirometry is insufficient for comprehensive assessment and staging of patients with mild COPD.
- Early identification of lung damage in COPD is critical for potentially altering disease trajectory.
- There is a need to include patients with early lung damage in clinical trials to better understand and treat the disease.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.0K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.0K
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K
01:26COPD: Management Using Bronchodilators and Corticosteroids
415
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
415
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.6K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.6K
01:20COPD: Pathogenesis and Clinical Features
630
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
630
01:22Chronic Obstructive Pulmonary Disease
1.5K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.5K